Is TRACON Pharmaceuticals Inc (TCON) The Right Choice in Biotechnology?

Thursday, September 24, 2020 2:46 PM | InvestorsObserver Analysts

TRACON Pharmaceuticals Inc (TCON) is around the top of the Biotechnology industry according to InvestorsObserver. TCON received an overall rating of 66, which means that it scores higher than 66 percent of all stocks. TRACON Pharmaceuticals Inc also achieved a score of 85 in the Biotechnology industry, putting it above 85 percent of Biotechnology stocks. Biotechnology is ranked 35 out of the 148 industries.

Overall Score - 66
TCON has an Overall Score of 66. Find out what this means to you and get the rest of the rankings on TCON!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. Investors Observer makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.

These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With TRACON Pharmaceuticals Inc Stock Today?

TRACON Pharmaceuticals Inc (TCON) stock is trading at $5.02 as of 2:43 PM on Thursday, Sep 24, an increase of $0.29, or 6.13% from the previous closing price of $4.73. The stock has traded between $4.10 and $5.17 so far today. Volume today is low. So far 946,980 shares have traded compared to average volume of 2,809,362 shares.

Click Here to get the full Stock Score Report on TRACON Pharmaceuticals Inc (TCON) Stock.

Share this article:

Related Companies

Upgrade to Premium and Analyze Stocks Like a Pro

50% Off All Subscriptions
InvestorsObserver Premium
InvestorsObserver Premium
InvestorsObserver Premium
Save up to 65% with annual

InvestorsObserver Premium

$ 20.75 $ 10.38 /month
$249 $124.50 billed annually

You May Also Like

Related Articles

Related Companies